s6y
Company name or ticker
Search
Oncotelic Therapeutics, Inc.
3
LOAR MATTHEW M: Initial statement of beneficial ownership of securities
Filed
Monday, July 20, 2015
Period
Jul 20, 2015
Accession number
0001209191-15-061698
Documents
FORM 3 SUBMISSION
3
POA DOCUMENT
EX-24.3_596409
On sec.gov
Filing index
All files
Complete submission text
SGML header